ليتروزول تيڤع

Страна: Израел

Език: арабски

Източник: Ministry of Health

Активна съставка:

LETROZOLE 2.5 MG

Предлага се от:

TEVA PHARMACEUTICAL INDUST.LTD

АТС код:

L02BG04

Лекарствена форма:

TABLETS

Начин на приложение:

PER OS

Произведено от:

TEVA PHARMACEUTICAL INDUSTRIES LTD

Терапевтична група:

LETROZOLE

Терапевтични показания:

Letrozole teva tablets is indicated for first-line treatment in postmenopausal women with hormone receptor positive or in whom hormone receptor status cannot be determined, locally advanced or metastatic breast cancer: Letrozole teva is also indicated for the treatment of advanced breast cancer in postmenopausal women with disease progression following antiestrogen therapy. Extended adjuvant treatment of early breast cancer in post menopausal women who have received prior standard adjuvant tamoxifen therapy. Adjuvant treatment of postmenopausal women with hormone receptor positive early breast cancer.

Дата Оторизация:

2010-01-01